文献速递妇科产科

早期卵巢癌前哨淋巴结活检的机器人手术技术

Surgical Technique for Sentinel Lymph Node Sampling in Presumed Early-stage Ovarian Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2020-12-30

本文通过视频演示一例37岁右附件复杂肿块疑似恶性患者,在机器人辅助下经子宫卵巢韧带注射稀释吲哚菁绿后识别并切除右侧主动脉旁前哨淋巴结,病理为IA期低级别浆液性卵巢癌,提示该技术在早期卵巢癌中可行。

要点

  • 机器人前哨淋巴结活检在早期卵巢癌中技术上可行。
  • 注射吲哚菁绿后8–10分钟可识别主动脉旁前哨淋巴结。
  • 该技术可能避免系统性淋巴结清扫。

核心结论

  • 前哨淋巴结取样在推测早期卵巢癌中看似可行,可能使这类患者避免系统性淋巴结清扫。

研究设计与样本

  • 视频报告,属于经机构审查委员会批准的研究,逐步演示机器人前哨淋巴结取样技术。
  • 患者为37岁女性,右附件10 cm复杂肿块,疑似恶性。

主要发现

  • 注射0.5 mL稀释吲哚菁绿溶液(1.25 mg/mL)至子宫卵巢韧带腹膜下后8–10分钟,识别右侧主动脉旁前哨淋巴结并完成 dissection。
  • 最终病理为IA期低级别浆液性卵巢癌。

关键数值与推荐

  • 系统性盆腔和主动脉旁淋巴结评估用于检测隐匿性III期病变,但淋巴结切除术与手术时间延长及13%淋巴囊肿形成风险相关。

临床怎么用

  • 在推测早期卵巢癌中,可考虑机器人辅助前哨淋巴结取样以替代系统性淋巴结清扫。

局限性

  • 前哨淋巴结活检仍处于研究阶段,尚无标准化方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Surgical staging for apparent early-stage ovarian cancer includes systematic pelvic and para-aortic lymph node evaluation to detect occult stage III disease [1]. Although, lymphadenectomy procedure is associated with increased duration of surgery and a 13% risk of lymphocyst formation [2]. Sentinel lymph node (SLN) biopsy is still investigational, and no standardized approach has been studied. Recent mounting evidence has approved the applicability of SLN technique in early-stage ovarian cancer [3,4]. The objective of this video is to demonstrate a surgical technique for robotic performance of SLN biopsy in presumed early-stage ovarian cancer. DESIGN: Stepwise demonstration of the robotic technique for SLN sampling in presumed early-stage ovarian cancer. This video report is part of an institutional, investigational review board-approved study. SETTING: Academic tertiary referral center. INTERVENTIONS: This video presents our team's robotic technique for SLN sampling in a 37-year-old woman who presented to our center with a 10-cm right complex adnexal mass, suspicious for malignancy. A 27-gauge spinal needle was inserted through the abdominal wall under direct visualization. We injected 0.5 mL of dilute indocyanine green solution (Novadaq Technologies, Mississauga, Ontario, Canada) (1.25 mg/mL) subperitoneally into the utero-ovarian ligament. The SLN was checked with the fluorescence-guided camera of the Xi DaVinci robotic system (Sunnyvale, CA). Eight to 10 minutes after the injection, a right para-aortic SLN was identified, and dissection was performed. After dissection, the node was extracted and sent to pathology for evaluation by ultra-staging. The final pathology revealed a stage IA low-grade serous ovarian cancer. CONCLUSION: SLN sampling appears to be feasible in presumed early-stage ovarian cancer and may allow the avoidance of systematic lymph node dissection in this set of patients.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Matanes E, Gupta V, Kogan L, et al. Surgical Technique for Sentinel Lymph Node Sampling in Presumed Early-stage Ovarian Cancer. J Minim Invasive Gynecol. 2020. PMID: 33387689. doi:10.1016/j.jmig.2020.12.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。